Business Context and Reporting Period
Company: Rambus Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2002
Business Overview: Rambus licenses chip-connection technology (RDRAM, SDRAM, DDR, RaSer) to semiconductor manufacturers. The company does not manufacture or sell devices directly but generates revenue through contract fees and royalties based on licensee shipments.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2002 |
Nine Months Ended June 30, 2002 |
Nine Months Ended June 30, 2001 |
|---|---|---|---|
| Total Revenues | $23,690 | $72,085 | $89,264 |
| Net Income | $5,897 | $18,819 | $24,789 |
| Operating Income | $7,649 | $23,924 | $32,402 |
| Net Cash from Operating Activities | N/A | $19,553 | $21,603 |
| Cash and Cash Equivalents | $30,982 | $30,982 | $57,741 |
| Total Assets | $232,851 | $232,851 | $237,790 |
| Working Capital | $90,108 | $90,108 | N/A |
Margins (Nine Months 2002): Operating margin was 33.2%; Net income margin was 26.1%.
Debt: The company reported no long-term debt. Total liabilities were $36.0 million, primarily consisting of deferred revenue ($28.3 million).
Material Changes vs. Prior Period
- Revenue: Total revenue for the nine months ended June 30, 2002, decreased 19.2% to $72.1 million compared to $89.3 million in the prior year. This was driven by a 66.7% decline in contract revenues due to the expiration of revenue recognition periods for several RDRAM contracts. Royalties decreased 6.4% to $65.8 million, attributed to fixed royalty agreements and declining Average Selling Prices (ASPs) for SDRAM/DDR memory.
- Expenses: Marketing, general, and administrative expenses decreased 26.7% to $26.2 million, largely due to a significant reduction in litigation costs ($8.5 million vs. $20.3 million in the prior year). Research and development expenses increased 22.9% to $16.2 million due to investments in RaSer and Yellowstone technologies.
- Profitability: Despite lower revenues, net income for the nine-month period decreased only 24.1% to $18.8 million, aided by reduced operating expenses. Operating income decreased 26.2% to $23.9 million.
- Liquidity: Cash and cash equivalents decreased by $13.2 million to $31.0 million. The company repurchased 2.5 million shares of common stock for approximately $16.3 million during the period.
Guidance, Outlook, and Risks
Management Commentary:
- Contract revenues are expected to remain relatively flat until significant new license agreements are negotiated.
- Future RDRAM royalties depend heavily on system sales by PC/workstation manufacturers and Sony.
- Revenue concentration remains high; the top five licensees accounted for approximately 84% of revenues in the first nine months of fiscal 2002.
- Management anticipates existing cash balances are adequate for at least the next 12 months.
Material Risks and Contingencies:
- Litigation: The company is involved in extensive litigation with Infineon, Micron, and Hynix regarding patent infringement and JEDEC standard-setting conduct. A permanent injunction in the U.S. against Infineon is currently under appeal. The Federal Trade Commission (FTC) filed a complaint in June 2002 alleging monopolization and unfair competition.
- Contingent Compensation: Significant non-cash charges could occur if contingent warrants, Common Stock Equivalents, and options vest based on stock price or volume milestones. Management estimates a potential charge of $100 million or more if triggered at a $25 stock price.
- Market Volatility: The company faces risks from declining DRAM prices, rapid technological changes, and dependence on a limited number of licensees and systems companies.
Investor Verification Checklist
- Litigation Outcomes: Monitor the status of the appeal in the Infineon case (CAFC) and the FTC complaint, as adverse rulings could result in injunctions, damages, or royalty-free licenses.
- Revenue Concentration: Verify the stability of the top three customers, who accounted for 72% of total revenues in the first nine months of 2002.
- Contingent Equity Charges: Assess the probability of vesting for contingent warrants and options, which could materially impact future earnings.
- Deferred Revenue: Review the $28.3 million in deferred revenue to understand the runway for future contract revenue recognition.
- Share Repurchases: Confirm the remaining authorization under the $5 million share repurchase program and its impact on dilution.